Table 5B.
Effect of vitamin D3 or omega-3s, compared to their matching placebos, on mean difference in change in PHQ-9 score over 2 years by quartiles of serum BDNF at baseline.
Vitamin D3 vs. placebo | Omega-3s vs. placebo | |||
---|---|---|---|---|
Mean difference (95% CI) |
P-interaction | Mean difference (95% CI) |
P-interaction | |
Quartiles of serum BDNF | 0.89 | 0.42 | ||
Lowest (Q1) (n=72) | 0.99 (0.53 to 1.85) | 0.91 (0.50 to 1.65) | ||
Second (Q2) (n=72) | 0.87 (0.42 to 1.79) | 1.37 (0.71 to 2.66) | ||
Third (Q3) (n=72) | 1.25 (0.66 to 2.36) | 1.48 (0.77 to 2.83) | ||
Highest (Q4) (n=72) | 0.69 (0.38 to 1.25) | 1.25 (0.69 to 2.26) |
Abbreviation: BDNF, brain-derived neurotrophic factor; PHQ, patient health questionnaire; CI, confidence interval Analyses were from repeated measures negative binomial regression models, with follow-up time modeled as an indicator. Results show RR and 95% CI, which reflect differences in the change in serum BDNF over 2 years comparing treatment agents and placebos. Models were controlled for age, sex, and concurrent randomization group. P-interaction is from the test of the BDNF quartile category-x-treatment-x-time interaction term in the model.